General Information of the Compound
| Compound ID |
CP0307324
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
8-[3-(4-Fluoro-phenoxy)-propyl]-1-methyl-3-propyl-1,3,8-triaza-spiro[4.5]decan-4-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H30FN3O2
|
||||||||||||||||||
| Molecular Weight |
363.477
|
||||||||||||||||||
| Canonical SMILES |
CCCN1CN(C)C2(CCN(CCCOc3ccc(F)cc3)CC2)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H30FN3O2/c1-3-11-24-16-22(2)20(19(24)25)9-13-23(14-10-20)12-4-15-26-18-7-5-17(21)6-8-18/h5-8H,3-4,9-16H2,1-2H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
YMVQALMWTZNEQG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01448, 5-hydroxytryptamine receptor 1A
Protein ID: PT01492, 5-hydroxytryptamine receptor 2A
Protein ID: PT01480, 5-hydroxytryptamine receptor 2C